Li-Mei Gu
Biographic Data
| ID | 7972854 |
|---|---|
| NAME | Li-Mei Gu |
| GIVEN NAMES | Li-Mei |
| FAMILY NAME | Gu |
| SIGNATURE | GU L |
| AFFILIATIONS | Guangzhou Medical University |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depression
Our exploratory, post-hoc analysis of an open-label, single-arm study suggests that patients with depression and a higher baseline BMI may experience greater reductions in depressive symptoms compared with those with a lower baseline BMI after receiving six ketamine infusions
A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
After six ketamine infusions, the improvement of anhedonic symptoms was found in both patients with melancholic and non-melancholic depression, and the efficacy was similar in both groups
Plasma Vegf Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
This preliminary finding does not support a role for VEGF in the antisuicidal effects of serial ketamine treatments in individuals with depression and suicidal ideation. Further research is needed to confirm and expand these findings
Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
The rates of antianhedonic response and remission to multiple ketamine infusions for the treatment of depression were similar between males and females. These findings should be verified by future studies, preferably randomized controlled trials (RCTs)
Association of Vegf With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
Objectives: To first explore the role of plasma vascular endothelial growth factor (VEGF) concentrations in ketamine's antianhedonic effects, focusing on Chinese patients with treatment-refractory depression (TRD). Methods: Seventy-eight patients with treatment-refractory major depressive disorder (MDD) or bipolar disorder (BD) were treated with six ketamine infusions (0.5 mg/kg). Levels of anhedonia were measured using the Montgomery-Åsberg Depr…
No prominent works on this page.
Association of Vegf With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
Objectives: To first explore the role of plasma vascular endothelial growth factor (VEGF) concentrations in ketamine's antianhedonic effects, focusing on Chinese patients with treatment-refractory depression (TRD). Methods: Seventy-eight patients with treatment-refractory major depressive disorder (MDD) or bipolar disorder (BD) were treated with six ketamine infusions (0.5 mg/kg). Levels of anhedonia were measured using the Montgomery-Åsberg Depr…
A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
After six ketamine infusions, the improvement of anhedonic symptoms was found in both patients with melancholic and non-melancholic depression, and the efficacy was similar in both groups
Plasma Vegf Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
This preliminary finding does not support a role for VEGF in the antisuicidal effects of serial ketamine treatments in individuals with depression and suicidal ideation. Further research is needed to confirm and expand these findings
Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
The rates of antianhedonic response and remission to multiple ketamine infusions for the treatment of depression were similar between males and females. These findings should be verified by future studies, preferably randomized controlled trials (RCTs)
Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depression
Our exploratory, post-hoc analysis of an open-label, single-arm study suggests that patients with depression and a higher baseline BMI may experience greater reductions in depressive symptoms compared with those with a lower baseline BMI after receiving six ketamine infusions
Depression (economics (5 works) · Ketamine (5 works) · Medicine (5 works) · Treatment of Major Depression (5 works) · Tryptophan and brain disorders (5 works) · Anesthesia (4 works) · Psychiatry (4 works) · Psychology (4 works) · Internal Medicine (3 works) · Major depressive disorder (3 works)